0001209191-21-055485.txt : 20210910
0001209191-21-055485.hdr.sgml : 20210910
20210910170849
ACCESSION NUMBER: 0001209191-21-055485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210910
DATE AS OF CHANGE: 20210910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galante Joseph C
CENTRAL INDEX KEY: 0001632384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 211247766
MAIL ADDRESS:
STREET 1: 111 TENTH AVENUE
STREET 2: SUITE 200
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-02
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001632384
Galante Joseph C
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2021-08-02
4
P
0
142
3.34
A
34973
D
Common Stock
2021-08-03
4
P
0
142
3.17
A
35115
D
Common Stock
2021-08-04
4
P
0
142
3.18
A
35257
D
Common Stock
2021-08-05
4
P
0
142
3.11
A
35399
D
Common Stock
2021-08-06
4
P
0
142
3.01
A
35541
D
Common Stock
2021-08-09
4
P
0
142
2.93
A
35683
D
Common Stock
2021-08-10
4
P
0
142
2.96
A
35825
D
Common Stock
2021-08-11
4
P
0
142
2.98
A
35967
D
Common Stock
2021-08-13
4
P
0
142
2.92
A
36109
D
Common Stock
2021-08-16
4
P
0
142
2.92
A
36251
D
Common Stock
2021-08-17
4
P
0
142
3.05
A
36393
D
Common Stock
2021-08-18
4
P
0
142
2.97
A
36535
D
Common Stock
2021-08-19
4
P
0
142
3.02
A
36677
D
Common Stock
2021-08-20
4
P
0
142
2.96
A
36819
D
Common Stock
2021-08-23
4
P
0
142
2.87
A
36961
D
Common Stock
2021-08-24
4
P
0
142
2.89
A
37103
D
Common Stock
2021-08-25
4
P
0
142
2.79
A
37245
D
Common Stock
2021-08-26
4
P
0
142
2.82
A
37387
D
Common Stock
2021-08-27
4
P
0
142
2.84
A
37529
D
Common Stock
2021-08-30
4
P
0
142
2.88
A
37671
D
Common Stock
2021-08-31
4
P
0
142
2.93
A
37813
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Joseph C. Galante by /s/ John Hamm as
attorney-in-fact
2021-09-10